Articles
Asia’s increasing levels of clinical trial industry competition are to your benefit
Biotechnology and pharmaceutical companies within the United States and Europe face an increasing number of hurdles when undertaking clinical trials within their own country or region; problems such as over...
Articles
New centre is tackling manufacturing challenge of cell therapy field
Stem cell science has made huge progress since the early 1960s when Canadian researchers James Till and Ernest McCulloch discovered blood stem cells and advanced...
Clinical Trials
Chi-Med Reports Preliminary Phase II data on Fruquintinib Combination in First-Line Lung Cancer
Hutchison China MediTech Limited reported preliminary clinical activity, safety, and tolerability data of fruquintinib, an investigational selective inhibitor of vascular endothelial growth factor receptor given...
Clinical Trials
MC2 Therapeutics A/S Announces First Patient Dosed in Pivotal US Phase 3 Trial in Psoriasis Vulgaris
MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company today announced that first patient has been dosed in its pivotal Phase 3 clinical trial...
Clinical Trials
OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines
OncoArendi Therapeutics announced today that this week the Company will initiate a Phase 1 study designed to assess the safety, tolerability and pharmacokinetics of its...
Clinical Trials
ABIVAX’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial
ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral diseases using its unique technology platform announced top-line results from the first cohort...
Clinical Trials
In Preclinical Trials Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection
Inovio Pharmaceuticals, Inc. announced that the development of its DNA-based monoclonal antibody program received a boost from two peer-reviewed scientific papers that demonstrate their impact...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.